Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.

Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.
复制标题

DOI:
10.1038/bjc.2011.34
复制
发表时间:
2011-03-15
影响因子:
8.8
通讯作者:
Rancourt, C.
Rancourt, C.
中科院分区:
医学1区
文献类型:
--
作者:
Comamala, M.;Pinard, M.;Theriault, C.;Matte, I.;Albert, A.;Boivin, M.;Beaudin, J.;Piche, A.;Rancourt, C.

文献摘要

参考文献

被引文献

相似文献

上皮性卵巢癌(EOC)细胞易于在整个腹膜腔内转移。上皮 - 间质转化(EMT)是转移性肿瘤进展的必要步骤。CA125/MUC16粘蛋白是一种高分子量糖蛋白,在大多数浆液性癌中过度表达,表明其在这些癌症的发病机制中可能起作用。 通过单链抗体介导的对过度表达的EOC NIH:OVCAR3细胞表面CA125/MUC16的敲低,研究了CA125/MUC16在上皮 - 间质转化中的作用。 CA125/MUC16的敲低与形态学改变相关,同时上皮标志物(E - 钙粘蛋白、细胞角蛋白 - 18)的表面表达降低,间质标志物(N - 钙粘蛋白、波形蛋白)的表达增加。免疫共沉淀实验表明,CA125/MUC16与E - 钙粘蛋白和β - 连环蛋白复合物结合。体外研究显示,CA125/MUC16敲低的细胞中细胞 - 细胞连接被破坏,运动性、迁移和侵袭性增强。在CA125/MUC16敲低的细胞中观察到表皮生长因子受体(EGFR)激活增强,同时Akt和ERK1/2磷酸化增加(它们是EGFR的下游效应物),以及基质金属蛋白酶 - 2(MMP - 2)和基质金属蛋白酶 - 9(MMP - 9)的表达和活性增加。表皮生长因子受体抑制强烈抑制了CA125/MUC16敲低细胞的运动性。 我们的研究结果表明,CA125/MUC16在上皮 - 间质转化中起作用,可能是通过其与E - 钙粘蛋白和β - 连环蛋白复合物的相互作用,以及调节NIH:OVCAR3细胞中的EGFR及其下游信号通路。
Epithelial ovarian cancer (EOC) cells are prone to metastasise throughout the peritoneal cavity. The epithelial-to-mesenchymal transition (EMT) is a necessary step towards metastatic tumour progression. CA125/MUC16 mucin is a high-molecular-weight glycoprotein overexpressed in the majority of serous carcinomas, suggesting a possible role in the pathogenesis of these cancers. The role of CA125/MUC16 in EMT was investigated using single-chain antibody-mediated knockdown of cell surface CA125/MUC16 in overexpressing EOC NIH:OVCAR3 cells. CA125/MUC16 knockdown was associated with morphological alterations along with decreased surface expression of epithelial markers (E-cadherin, cytokeratin-18) and increased expression of mesenchymal markers (N-cadherin, vimentin). Co-immunoprecipitation experiments revealed that CA125/MUC16 binds to E-cadherin and β-catenin complexes. The in vitro studies showed disruption of cell–cell junctions, enhanced motility, migration and invasiveness in CA125/MUC16 knockdown cells. Enhanced epidermal growth factor receptor (EGFR) activation was observed in CA125/MUC16 knockdown cells along with increased Akt and ERK1/2 phosphorylation, which are downstream effectors of EGFR, and increased MMP-2 and MMP-9 expression and activities. Epidermal growth factor receptor inhibition strongly inhibited the motility of CA125/MUC16 knockdown cells. Our findings suggest that CA125/MUC16 plays a role in EMT, presumably through its interaction with E-cadherin and β-catenin complexes and by modulating EGFR and its downstream signalling pathway in NIH:OVCAR3 cells.
DOI: 10.1038/sj.onc.1204106
发表时间: 2001-01-25
期刊: ONCOGENE
影响因子: 8
作者:
Komatsu, M;Jepson, S;Carraway, KL
通讯作者: Carraway, KL
DOI: 10.1159/000217821
发表时间: 1993-01-01
期刊: TUMOR BIOLOGY
影响因子: --
作者:
DELOSFRAILES, MT;STARK, S;WILDT, L
通讯作者: WILDT, L
DOI: 10.1016/j.ygyno.2006.09.028
发表时间: 2007-03-01
影响因子: 4.7
作者:
Hogdall, Estrid V. S.;Christensen, Lise;Hogdall, Claus K.
通讯作者: Hogdall, Claus K.
DOI: 10.1172/jci110380
发表时间: 1981-01-01
影响因子: 15.9
作者:
BAST, RC;FEENEY, M;KNAPP, RC
通讯作者: KNAPP, RC
DOI: 10.1159/000217716
发表时间: 1991-09-01
期刊: TUMOR BIOLOGY
影响因子: --
作者:
NAGATA, A;HIROTA, N;KOMODA, T
通讯作者: KOMODA, T